Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms — aTBS

Depression and Suicide Clinical Trial

Official title:
Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms

Status Completed

Clinical Trial Summary

This study evaluates an accelerated schedule of theta-burst stimulation for depressive symptoms in psychiatric inpatients. A small pilot study (n=22) will be carried out to demonstrate feasibility, using the FDA-approved stimulation site for depression treatment (L-DLPFC). Participants will be offered stimulation at the anterior cingulate cortex (ACC).

Clinical Trial Description

This study intends to investigate whether modifying stimulation parameters enables typical 6-8 week long rTMS protocols to be compressed to only five days. The influence of this accelerated protocol on the length of patient stay in the hospital will be investigated. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03601117
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2018
Completion date	June 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06009523` - Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation	N/A
Completed	`NCT02566980` - Biological Triggers of Depression in Pregnancy
Completed	`NCT04266288` - Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department	Phase 4
Recruiting	`NCT05437588` - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents	N/A
Recruiting	`NCT04760652` - Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention	N/A
Active, not recruiting	`NCT05930912` - Psychiatric Orders in Psychoanalytic Treatment of ASD
Recruiting	`NCT04572321` - Youth Depression and Suicide Research Network